BravoBio

China Biotech In Review: Simcere Receives $503 Million Privatization Offer
Seeking Alpha
Sun, 03/17/13 - 11:45 am
Simcere
Shanghai Pharmaceutical
Catalent
ShangPharma
Pathwork Diagnostics
Sinovac Biotech
BravoBio